Astellas, GSK vie to make "high altitude" anemia pill

By Ben Hirschler LONDON (Reuters) – Japan’s Astellas Pharma and Britain’s GlaxoSmithKline are competing to develop a new kind of medicine that boosts production of red blood cells by making the body think it is at high altitude. Their experimental drugs – both given as pills – could create a major new market in treating anemia and other serious conditions, including circulatory problems and wound damage. …